STOCK TITAN

Hyperion DeFi Inc SEC Filings

HYPD NASDAQ

Welcome to our dedicated page for Hyperion DeFi SEC filings (Ticker: HYPD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Hyperion DeFi, Inc. (NASDAQ: HYPD) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered tools to help interpret them. Hyperion DeFi’s filings describe its evolution from an ophthalmic technology company into a Hyperliquid-native DeFi business that builds and deploys a long-term strategic treasury of HYPE, the native token of the Hyperliquid blockchain, while continuing development of its Optejet User Filled Device.

Investors can review Form 8-K current reports that detail material events such as at-the-market equity program amendments, Sales Agreements with investment banks, HAUS agreements with DeFi partners, and the Joint Validator Operators’ Agreement for the Kinetiq × Hyperion validator node. Other 8-K filings describe leadership changes, including appointments of key executives, and press releases furnishing quarterly financial results and investor presentations.

Annual reports on Form 10-K and quarterly reports on Form 10-Q (when available) typically provide a broader view of Hyperion DeFi’s business model, including its digital asset treasury strategy, revenue components such as staking rewards, validator commissions, yield enhancement, DeFi monetization, and ecosystem rewards, as well as its ongoing life sciences activities around the Optejet User Filled Device. Proxy statements on Schedule 14A can offer additional detail on governance, board composition, and executive compensation.

On Stock Titan, these filings are updated in near real time as they are posted to the SEC’s EDGAR system. AI-powered summaries highlight key points from lengthy documents, helping readers understand how new agreements, capital raises, or digital asset strategies may affect Hyperion DeFi’s operations and risk profile. Users can also review Form 4 insider transaction reports to see how directors and officers are trading HYPD shares, and use AI explanations to interpret complex disclosures without wading through full-text filings.

Rhea-AI Summary

Forsakringsaktiebolaget Avanza Pension reports beneficial ownership of 863,087 shares of Hyperion DeFi, Inc. common stock, representing 10.19% of the class as shown in this amendment.

The filing lists 863,087 shares of sole voting power and 863,087 shares of shared dispositive power. The signature date on the amendment is 03/02/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Hyperion DeFi received an updated ownership report from Swedish insurer Forsakringsaktiebolaget Avanza Pension. The firm reports beneficial ownership of 841,843 shares of Hyperion DeFi common stock, representing 9.94% of the class as of the stated event date.

Avanza Pension has sole power to vote these 841,843 shares and shared power to dispose of the same amount. The shares are described as acquired and held in the ordinary course of business, not for the purpose of changing or influencing control of Hyperion DeFi.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Hyperion DeFi received an updated large-shareholder disclosure from Swedish insurer Forsakringsaktiebolaget Avanza Pension. The filing reports beneficial ownership of 856,666 shares of Hyperion DeFi common stock, representing 10.11% of the class as of the reporting date.

Avanza Pension has sole power to vote these 856,666 shares and shared power to dispose of them. The firm states the holdings were acquired and are held in the ordinary course of business, without the purpose or effect of changing or influencing control of Hyperion DeFi.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Rhea-AI Summary

Hyperion Defi, Inc. reported an equity award to its General Counsel, Robert Rubenstein. On January 12, 2026, he was granted 75,000 units of common stock with a reported price of $0 per share, increasing his beneficial ownership to 75,000 common shares reported as directly held.

According to the footnote, these units are restricted stock units (RSUs). Of the total, 37,500 RSUs are scheduled to vest on January 12, 2027, and the remaining 37,500 RSUs vest in four equal installments of 9,375 RSUs beginning three months after January 12, 2027 and then every three months until fully vested, conditioned on his continued employment through each vesting date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.15%
Tags
insider
-
Rhea-AI Summary

Hyperion DeFi, Inc. filed an initial insider ownership report for its General Counsel, Robert Rubenstein. This Form 3 identifies him as an officer of the company and confirms that, as of the event date of 01/12/2026, he reports no securities beneficially owned in Hyperion DeFi, Inc. The filing also includes a power of attorney as an exhibit, authorizing the signing of such ownership reports on his behalf.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.15%
Tags
insider
-
Rhea-AI Summary

Hyperion DeFi, Inc. reported insider share purchases by a director. A Form 4 filing shows open-market buys of 18,742 shares of common stock on 12/18/2025 at a volume-weighted average price of $3.1389 per share and an additional 19,702 shares at a volume-weighted average price of $3.1385 per share. These prices reflect multiple trades executed between $3.04 and $3.22 per share. Following these transactions, the reporting person beneficially owns 75,448 shares directly and 95,150 shares indirectly through a spouse.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Hyperion DeFi, Inc. entered into a Sales Agreement allowing an at-the-market offering of up to $500,000,000 of common stock under its Form S-3 shelf registration. The company can instruct Cantor Fitzgerald & Co. and Chardan Capital Markets, LLC to sell shares from time to time through regular market trades, block trades, or other permitted methods on The Nasdaq Capital Market or elsewhere. The Sales Agents will use commercially reasonable efforts to place the stock and will receive a commission equal to 4.0% of the gross sales proceeds for shares sold. Hyperion DeFi is not required to sell any shares, and the program will end when all authorized shares are sold or the agreement is terminated.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Hyperion DeFi, Inc. has filed a Form S-3 shelf registration to offer up to $1,000,000,000 of securities, including common stock, preferred stock, warrants, debt securities, units and rights, in one or more future offerings. Within this, a separate sales agreement prospectus covers up to $500,000,000 of common stock that may be issued from time to time through at-the-market transactions under a Sales Agreement with Cantor Fitzgerald & Co. and Chardan Capital Markets, LLC. The company’s common stock trades on Nasdaq under the symbol HYPD and last closed at $4.97 per share on November 13, 2025. As of September 30, 2025, Hyperion DeFi had 7,162,659 shares of common stock, 5,435,897 shares of Series A Preferred Stock and warrants to purchase 33,820,785 shares outstanding.

Hyperion DeFi, formerly Eyenovia, is building a strategic treasury of HYPE tokens tied to the Hyperliquid blockchain while operating a validator and related DeFi services, and it continues to develop its Optejet ophthalmic liquid delivery device. The company is a smaller reporting company and may use net proceeds from any future sales for general corporate purposes such as working capital, capital expenditures, debt repayment and potential acquisitions, with specific uses to be detailed in later prospectus supplements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration
-
Rhea-AI Summary

Hyperion DeFi, Inc. reported a sharp turnaround in Q3 2025 as it pivoted to a digital‑asset treasury strategy centered on HYPE tokens. Net income was $6.6 million for the quarter, compared with a loss a year ago, driven by realized and unrealized gains on HYPE and a gain on extinguishment of liabilities. Revenue reached $302,506 from native staking and validator commissions. Cash was $8.2 million, total assets $82.8 million, and stockholders’ equity improved to $70.8 million.

The company raised capital through an ATM and a private placement, including $50.0 million of Series A Preferred Stock with accompanying warrants, and expanded authorized shares. It began acquiring and staking HYPE in July, ending the quarter with HYPE digital assets of $37.95 million and digital intangible assets (primarily HiHYPE) of $35.02 million, offset by a $6.29 million impairment. The Avenue loan was amended to extend maturity to July 1, 2028, reduce the rate to 8% (half cash/half PIK), and add warrants. Common shares outstanding were 7,162,659 as of September 30, 2025; 8,097,659 as of November 10, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.8%
Tags
quarterly report
Rhea-AI Summary

Hyperion DeFi, Inc. announced its financial results for the quarter ended September 30, 2025. The company made a press release available and provided an investor presentation to accompany the disclosure.

Hyperion DeFi is hosting a conference call on November 13, 2025 to discuss its quarterly financial and operating results. The company’s common stock trades on the Nasdaq Capital Market under the symbol HYPD.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.8%
Tags
current report

FAQ

What is the current stock price of Hyperion DeFi (HYPD)?

The current stock price of Hyperion DeFi (HYPD) is $3.29 as of March 10, 2026.

What is the market cap of Hyperion DeFi (HYPD)?

The market cap of Hyperion DeFi (HYPD) is approximately 28.8M.

HYPD Rankings

HYPD Stock Data

28.81M
5.43M
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW YORK

HYPD RSS Feed